Paul M. Silva's Insider Trades & SAST Disclosures
Paul M. Silva's most recent trade in Nurix Therapeutics Inc was a trade of 25,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 19, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul M. Silva.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 25,000 | 25,000 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 17,500 | 17,500 | - | - | Director Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 35,000 | 35,000 | - | - | Director Stock Option (right to buy) | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.42 per share. | 26 Feb 2021 | 2,218 | 12,666 (0%) | 0% | 212.4 | 471,148 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 210.13 per share. | 26 Feb 2021 | 1,026 | 11,640 (0%) | 0% | 210.1 | 215,593 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 212.51 per share. | 26 Feb 2021 | 915 | 10,115 (0%) | 0% | 212.5 | 194,447 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 211.45 per share. | 26 Feb 2021 | 610 | 11,030 (0%) | 0% | 211.5 | 128,985 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 213.12 per share. | 26 Feb 2021 | 231 | 9,884 (0%) | 0% | 213.1 | 49,231 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.57 per share. | 24 Feb 2021 | 864 | 15,964 (0%) | 0% | 217.6 | 187,980 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 213.12 per share. | 24 Feb 2021 | 452 | 15,268 (0%) | 0% | 213.1 | 96,330 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 214.32 per share. | 24 Feb 2021 | 258 | 15,010 (0%) | 0% | 214.3 | 55,295 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 211.80 per share. | 24 Feb 2021 | 244 | 15,720 (0%) | 0% | 211.8 | 51,679 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 216.25 per share. | 24 Feb 2021 | 126 | 14,884 (0%) | 0% | 216.3 | 27,248 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.75 per share. | 17 Feb 2021 | 2,740 | 21,123 (0%) | 0% | 211.8 | 580,195 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 211.82 per share. | 17 Feb 2021 | 2,343 | 18,196 (0%) | 0% | 211.8 | 496,294 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 212.62 per share. | 17 Feb 2021 | 1,368 | 16,828 (0%) | 0% | 212.6 | 290,864 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 210.05 per share. | 17 Feb 2021 | 584 | 20,539 (0%) | 0% | 210.0 | 122,669 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 210.45 per share. | 11 Feb 2021 | 1,288 | 24,073 (0%) | 0% | 210.5 | 271,060 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 211.32 per share. | 11 Feb 2021 | 210 | 23,863 (0%) | 0% | 211.3 | 44,377 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.16 per share. | 10 Feb 2021 | 651 | 25,361 (0%) | 0% | 214.2 | 139,418 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 4,220 | 19,152 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 3,634 | 26,012 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 3,226 | 22,378 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 612 | 3,669 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 155.57 per share. | 06 Aug 2020 | 612 | 16,010 (0%) | 0% | 155.6 | 95,209 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 466 | 4,656 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 187.53 per share. | 06 Aug 2020 | 466 | 15,398 (0%) | 0% | 187.5 | 87,389 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 270.12 per share. | 06 Aug 2020 | 420 | 15,590 (0%) | 0% | 270.1 | 113,450 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 272.15 per share. | 06 Aug 2020 | 373 | 15,006 (0%) | 0% | 272.2 | 101,512 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 270.92 per share. | 06 Aug 2020 | 211 | 15,379 (0%) | 0% | 270.9 | 57,164 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 272.86 per share. | 06 Aug 2020 | 74 | 14,932 (0%) | 0% | 272.9 | 20,192 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2020 | 809 | 1,618 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.52 per share. | 03 Aug 2020 | 809 | 15,741 (0%) | 0% | 86.5 | 69,995 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 278.92 per share. | 03 Aug 2020 | 429 | 14,951 (0%) | 0% | 278.9 | 119,657 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 277.73 per share. | 03 Aug 2020 | 310 | 15,380 (0%) | 0% | 277.7 | 86,096 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 276.00 per share. | 03 Aug 2020 | 51 | 15,690 (0%) | 0% | 276 | 14,076 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 279.63 per share. | 03 Aug 2020 | 19 | 14,932 (0%) | 0% | 279.6 | 5,313 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.29 per share. | 13 Jul 2020 | 860 | 15,792 (0%) | 0% | 90.3 | 77,649 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2020 | 860 | 0 | - | - | Stock Options (Right to Buy) | |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 294.99 per share. | 13 Jul 2020 | 250 | 15,032 (0%) | 0% | 295.0 | 73,748 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 294.18 per share. | 13 Jul 2020 | 200 | 15,282 (0%) | 0% | 294.2 | 58,836 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 295.78 per share. | 13 Jul 2020 | 100 | 14,932 (0%) | 0% | 295.8 | 29,578 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 284.56 per share. | 13 Jul 2020 | 100 | 15,692 (0%) | 0% | 284.6 | 28,456 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 287.86 per share. | 13 Jul 2020 | 100 | 15,532 (0%) | 0% | 287.9 | 28,786 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 285.72 per share. | 13 Jul 2020 | 60 | 15,632 (0%) | 0% | 285.7 | 17,143 | Common Stock |
| Vertex Pharmaceuticals, Inc. | Paul M. Silva | SVP & Controller | Sale of securities on an exchange or to another person at price $ 291.98 per share. | 13 Jul 2020 | 50 | 15,482 (0%) | 0% | 292.0 | 14,599 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges